NCT06410144

Outcomes of a Palliative Care Intervention to Improve Kidney Therapy Decision-Making for Older People With Advanced Chronic Kidney Disease (CKD)

University of Rochester·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Chronic Kidney Diseases
Drug/Device/Intervention
CKD-EDU
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Rochester
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
May 01, 2029
Enrollment
326 participants
Primary outcome

Changes in Kidney Therapy Decision-Making Process using the Decisional Conflict Scale at 4-6 weeks

Summary

The investigators are conducting a study to see if an educational program called Chronic
 Kidney Disease-Education (CKD-EDU) can help make better kidney therapy decisions and improve
 the well-being of older adults. Investigators are also investigating if this program can
 reduce the number of hospital or emergency room visits in the first 6 months of the study, as
 well as potentially improve end-of-life care for older adults.
 
 Half of the participants will receive the CKD-EDU intervention, while the other half will
 continue with their usual nephrology care. Investigators will compare the two groups to see
 if participants who received the intervention feel better prepared about their kidney therapy
 decisions, experience improved end-of-life care, and have fewer emergency room visits,
 hospital admissions,
 
 Participants in the intervention group will get information about kidney disease treatment
 and meet with a palliative care specialist who's an expert in decision-making.

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06410144
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06410144 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Rochester and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases. Target enrollment is 326 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.